Aquestive Therapeutics, Inc. (AQST)
4.80
+0.14
(+3.00%)
USD |
NASDAQ |
Aug 24, 16:00
4.71
-0.09
(-1.88%)
After-Hours: 20:00
Aquestive Therapeutics Shareholders Equity (Quarterly) : -56.59M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -56.59M |
| March 31, 2026 | -34.05M |
| December 31, 2025 | -33.66M |
| September 30, 2025 | -4.109M |
| June 30, 2025 | -72.59M |
| March 31, 2025 | -60.93M |
| December 31, 2024 | -60.16M |
| September 30, 2024 | -45.42M |
| June 30, 2024 | -35.48M |
| March 31, 2024 | -36.30M |
| December 31, 2023 | -106.49M |
| September 30, 2023 | -102.93M |
| June 30, 2023 | -106.65M |
| March 31, 2023 | -109.24M |
| December 31, 2022 | -118.55M |
| September 30, 2022 | -107.82M |
| June 30, 2022 | -96.36M |
| March 31, 2022 | -93.14M |
| Date | Value |
|---|---|
| December 31, 2021 | -82.13M |
| September 30, 2021 | -60.34M |
| June 30, 2021 | -53.77M |
| March 31, 2021 | -51.80M |
| December 31, 2020 | -48.50M |
| September 30, 2020 | -36.52M |
| June 30, 2020 | -21.39M |
| March 31, 2020 | -20.83M |
| December 31, 2019 | -6.122M |
| September 30, 2019 | -34.46M |
| June 30, 2019 | -24.66M |
| March 31, 2019 | -6.056M |
| December 31, 2018 | 10.08M |
| September 30, 2018 | 23.44M |
| June 30, 2018 | -38.95M |
| March 31, 2018 | -22.40M |
| December 31, 2017 | -26.50M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 219.26M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.10M |
| Total Liabilities (Quarterly) | 188.69M |
| Debt to Equity Ratio | -2.635 |
| Current Ratio | 7.191 |
| Net Debt Paydown Yield | -0.94% |